Published in Int J Nanomedicine on August 30, 2013
Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa. Int J Nanomedicine (2014) 0.88
Nanomedicine in the Management of Microbial Infection - Overview and Perspectives. Nano Today (2014) 0.87
pH-Controlled Cerium Oxide Nanoparticle Inhibition of Both Gram-Positive and Gram-Negative Bacteria Growth. Sci Rep (2017) 0.75
Cerium oxide nanoparticle treatment ameliorates peritonitis-induced diaphragm dysfunction. Int J Nanomedicine (2015) 0.75
Disinfection effects of undoped and silver-doped ceria powders of nanometer crystallite size. Int J Nanomedicine (2016) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58
Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis (2005) 9.06
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest (2005) 5.91
Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano (2008) 5.68
Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett (2005) 2.71
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials (2007) 2.62
Direct oxidation of hydrocarbons in a solid-oxide fuel cell Nature (2000) 2.36
Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science (2004) 1.99
Oxidase-like activity of polymer-coated cerium oxide nanoparticles. Angew Chem Int Ed Engl (2009) 1.78
Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol (2003) 1.70
Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano (2010) 1.61
Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg (2002) 1.51
Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am J Respir Crit Care Med (1999) 1.48
Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest (2004) 1.45
Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small (2008) 1.30
Novel synthesis of cerium oxide nanoparticles for free radical scavenging. Nanomedicine (Lond) (2007) 1.05
Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000. J Hosp Infect (2003) 0.99
The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials (2009) 2.28
Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials (2004) 2.02
Oxidase-like activity of polymer-coated cerium oxide nanoparticles. Angew Chem Int Ed Engl (2009) 1.78
Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine (2011) 1.72
Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine (2011) 1.71
Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small (2009) 1.64
Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano (2010) 1.61
Selective bone cell adhesion on formulations containing carbon nanofibers. Biomaterials (2003) 1.57
Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine (2012) 1.51
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials (2004) 1.49
Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A (2006) 1.49
Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials (2006) 1.45
The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials (2008) 1.43
Enhanced fibronectin adsorption on carbon nanotube/poly(carbonate) urethane: independent role of surface nano-roughness and associated surface energy. Biomaterials (2007) 1.41
Polymers with nano-dimensional surface features enhance bladder smooth muscle cell adhesion. J Biomed Mater Res A (2003) 1.37
Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials (2003) 1.34
Polymeric nanoparticle preparation that eradicates tumors. Nano Lett (2005) 1.33
Nanometer surface roughness increases select osteoblast adhesion on carbon nanofiber compacts. J Biomed Mater Res A (2004) 1.31
Enhanced functions of osteoblasts on nanometer diameter carbon fibers. Biomaterials (2002) 1.29
Nanotechnology for regenerative medicine. Biomed Microdevices (2010) 1.27
One-step, nanoparticle-mediated bacterial detection with magnetic relaxation. Nano Lett (2007) 1.26
The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine (2009) 1.25
Nano rough micron patterned titanium for directing osteoblast morphology and adhesion. Int J Nanomedicine (2008) 1.24
Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv Drug Deliv Rev (2009) 1.21
Nanotextured titanium surfaces for enhancing skin growth on transcutaneous osseointegrated devices. Acta Biomater (2009) 1.21
Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng (2002) 1.21
Novel nanosensors for rapid analysis of telomerase activity. Cancer Res (2004) 1.20
Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater (2007) 1.19
The influence of nano MgO and BaSO4 particle size additives on properties of PMMA bone cement. Int J Nanomedicine (2008) 1.17
Enhanced osteoblast functions on anodized titanium with nanotube-like structures. J Biomed Mater Res A (2008) 1.17
Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int J Nanomedicine (2010) 1.17
Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. Adv Drug Deliv Rev (2009) 1.16
Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. J Biomed Mater Res A (2006) 1.16
Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology (2011) 1.15
Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials (2005) 1.12
Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials (2005) 1.11
Nanotechnology for bone materials. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.10
Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces. Int J Nanomedicine (2008) 1.09
Enhanced chondrocyte densities on carbon nanotube composites: the combined role of nanosurface roughness and electrical stimulation. J Biomed Mater Res A (2008) 1.09
Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. J Am Chem Soc (2011) 1.09
TiO2 nanotubes functionalized with regions of bone morphogenetic protein-2 increases osteoblast adhesion. J Biomed Mater Res A (2008) 1.08
Iron oxide nanoparticles: hidden talent. Nat Nanotechnol (2007) 1.08
Helical rosette nanotubes: a biomimetic coating for orthopedics? Biomaterials (2005) 1.08
Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. J Biomed Mater Res A (2005) 1.07
Decreased fibroblast cell density on chemically degraded poly-lactic-co-glycolic acid, polyurethane, and polycaprolactone. Biomaterials (2004) 1.07
Biologically inspired rosette nanotubes and nanocrystalline hydroxyapatite hydrogel nanocomposites as improved bone substitutes. Nanotechnology (2009) 1.06
Arginine-glycine-aspartic acid modified rosette nanotube-hydrogel composites for bone tissue engineering. Biomaterials (2008) 1.05
Reduced adhesion of macrophages on anodized titanium with select nanotube surface features. Int J Nanomedicine (2011) 1.05
Greater osteoblast proliferation on anodized nanotubular titanium upon electrical stimulation. Int J Nanomedicine (2008) 1.04
Nanofunctionalized zirconia and barium sulfate particles as bone cement additives. Int J Nanomedicine (2010) 1.04
Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy. Mol Pharm (2010) 1.03
Enhanced osteoblast adhesion on hydrothermally treated hydroxyapatite/titania/poly(lactide-co-glycolide) sol-gel titanium coatings. Biomaterials (2005) 1.03
Osteoblast function on nanophase alumina materials: Influence of chemistry, phase, and topography. J Biomed Mater Res A (2003) 1.02
Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater (2010) 1.01
Nanocrystalline hydroxyapatite/titania coatings on titanium improves osteoblast adhesion. J Biomed Mater Res A (2008) 1.00
Decreased functions of astrocytes on carbon nanofiber materials. Biomaterials (2003) 0.99
Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater (2011) 0.98
An overview of nano-polymers for orthopedic applications. Macromol Biosci (2007) 0.98
Increased chondrocyte adhesion on nanotubular anodized titanium. J Biomed Mater Res A (2009) 0.98
Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. J Nanosci Nanotechnol (2006) 0.98
Enhanced functions of vascular cells on nanostructured Ti for improved stent applications. Tissue Eng (2007) 0.98
Decreased Staphylococcus aureus biofilm growth on anodized nanotubular titanium and the effect of electrical stimulation. Acta Biomater (2011) 0.97
Nanotechnology and biomaterials for orthopedic medical applications. Nanomedicine (Lond) (2006) 0.97
Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology (2008) 0.96
Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Deliv (2009) 0.96
Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J Am Chem Soc (2009) 0.96
Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications. Expert Rev Med Devices (2004) 0.96
Enhanced osteoblast adhesion on self-assembled nanostructured hydrogel scaffolds. Tissue Eng Part A (2008) 0.95
Greater osteoblast and endothelial cell adhesion on nanostructured polyethylene and titanium. Int J Nanomedicine (2010) 0.94
Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material. J Biomed Mater Res A (2010) 0.94
Electrically controlled drug release from nanostructured polypyrrole coated on titanium. Nanotechnology (2011) 0.94
The impact of diamond nanocrystallinity on osteoblast functions. Biomaterials (2009) 0.93
Nanomedicine: what's in a definition? Int J Nanomedicine (2006) 0.93
PLGA nanometer surface features manipulate fibronectin interactions for improved vascular cell adhesion. J Biomed Mater Res A (2007) 0.93
Enhanced endothelial cell density on NiTi surfaces with sub-micron to nanometer roughness. Int J Nanomedicine (2008) 0.93
Biomimetic helical rosette nanotubes and nanocrystalline hydroxyapatite coatings on titanium for improving orthopedic implants. Int J Nanomedicine (2008) 0.93
Decreased bacteria activity on Si₃N₄ surfaces compared with PEEK or titanium. Int J Nanomedicine (2012) 0.93
Nanometer polymer surface features: the influence on surface energy, protein adsorption and endothelial cell adhesion. Nanotechnology (2008) 0.93
Increased osteoblast adhesion on nanograined hydroxyapatite and partially stabilized zirconia composites. J Biomed Mater Res A (2006) 0.92
Induction of apoptosis in cancer cells by NiZn ferrite nanoparticles through mitochondrial cytochrome C release. Int J Nanomedicine (2013) 0.92
Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies. Int J Nanomedicine (2010) 0.91
Aliphatic hyperbranched polyester: a new building block in the construction of multifunctional nanoparticles and nanocomposites. Langmuir (2010) 0.91
Anodized 20 nm diameter nanotubular titanium for improved bladder stent applications. Int J Nanomedicine (2011) 0.91
The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation. Nanotechnology (2009) 0.91
Enhanced osteoblast adhesion on nanostructured selenium compacts for anti-cancer orthopedic applications. Int J Nanomedicine (2008) 0.91
Mechanical properties of dispersed ceramic nanoparticles in polymer composites for orthopedic applications. Int J Nanomedicine (2010) 0.91
Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomedicine (2012) 0.91
Antibacterial effect of zinc oxide nanoparticles combined with ultrasound. Nanotechnology (2012) 0.91
Fructose-enhanced reduction of bacterial growth on nanorough surfaces. Int J Nanomedicine (2012) 0.90
Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method. J Biomed Mater Res B Appl Biomater (2009) 0.90
Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small (2012) 0.90
Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J Biomed Mater Res A (2009) 0.90
Silver nanoparticle toxicity in Drosophila: size does matter. Int J Nanomedicine (2011) 0.90
Increased osteoblast functions on nanophase titania dispersed in poly-lactic-co-glycolic acid composites. Nanotechnology (2005) 0.90
Increased endothelial cell adhesion and elongation on micron-patterned nano-rough poly(dimethylsiloxane) films. Nanotechnology (2009) 0.90
Nanotechnology: pediatric applications. Pediatr Res (2010) 0.90
Rapid nanoparticle-mediated monitoring of bacterial metabolic activity and assessment of antimicrobial susceptibility in blood with magnetic relaxation. PLoS One (2008) 0.90
Comparison of quantification methods illustrates reduced Pseudomonas aeruginosa activity on nanorough polyvinyl chloride. J Biomed Mater Res B Appl Biomater (2011) 0.89
Increased osteoblast cell density on nanostructured PLGA-coated nanostructured titanium for orthopedic applications. Int J Nanomedicine (2007) 0.89